I'm curious as to what holders are thinking now. Ramping aside (everyone has an agenda), are people willing to hold out for the quarterly to see where we actually are or is this the final straw?
The status of HCT is so confusing. All these performance options that are totally unrealistic given what happened yesterday. The marketing and PR engagement and yet announcements still getting put out that are utterly amateurish. Sales failure. So many trials and relationships with distribution that just seem to evaporate.
And yet... still an amazing product line with so much potential.
As we all know, potential isn't the bottom line but where from here?
Ann: Update on Sales and Distribution Agreements for Natshield, page-328
-
- There are more pages in this discussion • 153 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add HCT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.951M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 647922 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 494947 | 6 |
View Market Depth
| Last trade - 11.05am 30/07/2024 (20 minute delay) ? |
| HCT (ASX) Chart |
Day chart unavailable